ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1047
-0,50%
Bitcoin
66.820,14
2,42%
Brent Oil
83,76
0,67%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Eli Lilly And Co (0Q1G)

  7. Eli Lilly And Co (0Q1G) Notícias

0Q1G

Eli Lilly (0Q1G)

Eli Lilly And Co
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:0Q1G
DataHoraFonteTítuloCódigoCompanhia
15/05/202417:07Alliance NewsAlliance NewsEli Lilly reaches settlement with Totality MedispaLSE:0Q1GEli Lilly And Co
30/04/202409:26Alliance NewsAlliance NewsTOP NEWS: Eli Lilly lifts outlook, ramps up production to meet demandLSE:0Q1GEli Lilly And Co
08/03/202412:16Alliance NewsAlliance NewsEli Lilly's Donanemab Alzheimer's drug hit by delaysLSE:0Q1GEli Lilly And Co
06/02/202409:44Alliance NewsAlliance NewsTOP NEWS: Eli Lilly eyes beefier sales amid weight loss drug crazeLSE:0Q1GEli Lilly And Co
26/01/202403:04Alliance NewsAlliance NewsEli Lilly weight loss drug could be supplied to UK 'in weeks'LSE:0Q1GEli Lilly And Co
23/01/202415:48Alliance NewsAlliance NewsIN BRIEF: Eli Lilly hails upbeat trial data for hearing loss therapyLSE:0Q1GEli Lilly And Co
17/11/202311:18Alliance NewsAlliance NewsTOP NEWS: Eli Lilly to invest USD2.5 billion in GermanyLSE:0Q1GEli Lilly And Co
09/11/202303:09Alliance NewsAlliance NewsEli Lilly diabetes drug authorised for weight management, loss in UKLSE:0Q1GEli Lilly And Co
08/11/202317:15Alliance NewsAlliance NewsUS approves highly anticipated Eli Lilly weight loss drugLSE:0Q1GEli Lilly And Co
02/11/202308:42Alliance NewsAlliance NewsTOP NEWS: Eli Lilly cuts yearly outlook on chunky R&D costsLSE:0Q1GEli Lilly And Co
08/08/202308:23Alliance NewsAlliance NewsTOP NEWS: Eli Lilly second quarter profit up, notes pipeline successesLSE:0Q1GEli Lilly And Co
21/06/202315:34Alliance NewsAlliance NewsUS FDA approves Eli Lilly's Jardiance drug for diabetes in childrenLSE:0Q1GEli Lilly And Co
27/04/202309:28Alliance NewsAlliance NewsTOP NEWS: Eli Lilly quarterly revenue down on reduced Covid-19 demandLSE:0Q1GEli Lilly And Co
03/03/202318:20Alliance NewsAlliance NewsIN BRIEF: US FDA approves expanded indication for Eli Lilly's VerzenioLSE:0Q1GEli Lilly And Co
01/03/202310:42Alliance NewsAlliance NewsUS drugmaker Eli Lilly says slashing insulin prices by 70%LSE:0Q1GEli Lilly And Co
02/02/202317:17Alliance NewsAlliance NewsEli Lilly & Co sees quarterly revenue fall amid declining volumesLSE:0Q1GEli Lilly And Co
01/11/202213:24Alliance NewsAlliance NewsEli Lilly lowers full year guidance despite positive earnings figuresLSE:0Q1GEli Lilly And Co
04/08/202208:23Alliance NewsAlliance NewsTOP NEWS: Eli Lilly cuts annual guidance as second quarter disappointsLSE:0Q1GEli Lilly And Co
03/02/202212:17Alliance NewsAlliance NewsEli Lilly sees net income fall but outlook for 2022 remains unchangedLSE:0Q1GEli Lilly And Co
 Apresentando as notícias mais relevantes sobre:LSE:0Q1G

Seu Histórico Recente

COIN
PCTGBP
LSE
USDG
Lg Esg Usd
NASDAQ
GEOS
Geospace Technologies
COIN
MEDUST
MediBloc
LSE
ZU10
Ebrd 25
LSE
LXUU
Ubs Etc Zinc U
LSE
AMT
Amstrad
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados